SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-12-236832
Filing Date
2012-05-16
Accepted
2012-05-16 17:28:23
Documents
8
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-K d340139d10ka.htm 10-K/A 180848
2 LICENSE AGREEMENT d340139dex10131.htm EX-10.131 335590
3 LICENSE AND SUPPLY AGREEMENT d340139dex10133.htm EX-10.133 351357
4 CONSENT OF GRANT THORNTON LLP d340139dex231.htm EX-23.1 1869
5 CERTIFICATION d340139dex311.htm EX-31.1 6731
6 CERTIFICATION d340139dex312.htm EX-31.2 6764
7 CERTIFICATION d340139dex321.htm EX-32.1 4371
8 CERTIFICATION d340139dex322.htm EX-32.2 4363
  Complete submission text file 0001193125-12-236832.txt   892938
Mailing Address 11085 NORTH TORREY PINES ROAD SUITE 300 LA JOLLA CA 92037
Business Address 11085 NORTH TORREY PINES ROAD SUITE 300 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-33093 | Film No.: 12849744
SIC: 2834 Pharmaceutical Preparations